NCT01389700View on ClinicalTrials.gov

Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Infection Prophylaxis
Interventions
DRUG

SAR279356

"Pharmaceutical form: solution for infusion~Route of administration: intravenous infusion"

DRUG

placebo

"Pharmaceutical form: solution for infusion~Route of administration: intravenous infusion"

Trial Locations (6)

32209

Investigational Site Number 840006, Jacksonville

41501

Investigational Site Number 840001, Pikeville

59701

Investigational Site Number 840009, Butte

90024

Investigational Site Number 840010, Los Angeles

94305

Investigational Site Number 840020, Stanford

08103

Investigational Site Number 840003, Camden

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT01389700 - Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients | Biotech Hunter | Biotech Hunter